학술논문
Tissue Factor Pathway Inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancer
Document Type
Article
Author
Source
Hämostaseologie; February 2023, Vol. 43 Issue: 1, Number 1 Supplement 1
Subject
Language
ISSN
07209355; 25675761